PED
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 20 | +12 | 559.49K | $7.53M | +14 | −2 |
| Q1 2026 | 8 | -4 | 112.41K | $1.80M | +3 | −7 |
| Q4 2025 | 12 | 0 | 1.87M | $1.04M | +1 | −1 |
| Q3 2025 | 5 | -2 | 1.64M | $945,334 | — | −2 |
| Q2 2025 | 6 | 0 | 1.64M | $1.08M | — | — |
| Q1 2025 | 5 | -1 | 730.19K | $511,937 | — | −1 |
| Q4 2024 | 6 | 0 | 903.04K | $702,894 | — | — |
| Q3 2024 | 5 | 0 | 632.24K | $595,312 | — | — |
| Q2 2024 | 5 | — | 656.99K | $594,356 | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 238.97K | — | $216,230 | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 238.97K | — | $216,230 | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 227.81K | — | $206,081 | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 107.48K | — | $97,226 | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 57.50K | — | $52,000 | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 25.23K | — | $22,819 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 15 holders, 7.08M shares, $113.34M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 1.22K sh · $15,067
Officer · 5.28K sh · $66,121
Officer · 3.77K sh · $48,230
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology